Returning from Targeting-Victory in Wangji Targeted Therapy of Lung Cancer

Primary lung cancer (hereinafter referred to as lung cancer) is one of the most common malignant tumors in the world and in China

Targeted therapy of lung cancer is a good news for patients with advanced non-small cell lung cancer.

Among the many lung cancer targets, there is a gene mutation called the "diamond mutation".

The Department of Respiratory Medicine of the Right Medical Affiliated Hospital has carried out lung cancer genetic testing in the past three years.

Case 1: Patient Li Moumou, female, 67 years old, was hospitalized in our department in June 2019 due to left lung cancer with multiple metastases throughout the body.

Lung CT on June 22, 2021

CT of the lungs on July 23, 2021

Liver metastasis lesions have also shrunk significantly after 1 month

Case 2: Patient Lu Moumou, female, 81 years old, was diagnosed in our department in September 2020 as right upper lobe lung cancer, right upper lobe obstructive atelectasis, and the anterior opening of the right upper lobe can be seen under fiberoptic bronchoscopy It can be seen that a new organism completely blocked the airway, bronchial biopsy revealed lung adenocarcinoma, genetic testing revealed EGFR mutation, 19-Del exon 19 deletion, and the first-generation targeted drug icotinib was selected according to the condition of the disease.

CT scan of lung window, mediastinal window and fiberoptic bronchoscopy on September 5, 2020

CT scan of lung window, mediastinal window and fiberoptic bronchoscopy on October 9, 2020

The above is the use of targeted drug therapy for advanced lung cancer patients in our department.